Mary Rieck

3.0k total citations · 1 hit paper
22 papers, 2.3k citations indexed

About

Mary Rieck is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Mary Rieck has authored 22 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Mary Rieck's work include T-cell and B-cell Immunology (10 papers), Diabetes and associated disorders (8 papers) and Immune Cell Function and Interaction (7 papers). Mary Rieck is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Diabetes and associated disorders (8 papers) and Immune Cell Function and Interaction (7 papers). Mary Rieck collaborates with scholars based in United States, Sweden and Australia. Mary Rieck's co-authors include Jane H. Buckner, Carla J. Greenbaum, Srinath Sanda, S. Alice Long, Jeffrey A. Bluestone, Mark Fitch, Catherine Pihoker, Marc K. Hellerstein, Angela Lares and Vinh Nguyen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Mary Rieck

22 papers receiving 2.3k citations

Hit Papers

Type 1 diabetes immunotherapy using polyclonal regulatory... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Rieck United States 16 1.4k 860 488 380 366 22 2.3k
Kathrine Skarstein Norway 24 701 0.5× 418 0.5× 529 1.1× 289 0.8× 114 0.3× 55 2.1k
Mauro Congia Italy 25 1.0k 0.7× 1.1k 1.3× 653 1.3× 447 1.2× 412 1.1× 50 2.7k
Thomas Eiermann Germany 25 1.0k 0.7× 244 0.3× 359 0.7× 362 1.0× 114 0.3× 65 2.0k
Sylvie Grégoire France 18 813 0.6× 233 0.3× 303 0.6× 368 1.0× 88 0.2× 29 1.7k
Laura Crisá United States 17 778 0.5× 374 0.4× 384 0.8× 319 0.8× 213 0.6× 24 1.5k
Isabella Cascino Italy 19 596 0.4× 256 0.3× 147 0.3× 673 1.8× 152 0.4× 35 1.4k
Danling Gu United States 20 283 0.2× 1.0k 1.2× 862 1.8× 1.0k 2.7× 387 1.1× 42 2.2k
Cheng‐Chi Chao United States 13 1.1k 0.8× 264 0.3× 170 0.3× 399 1.1× 59 0.2× 28 1.7k
Nicolas Degauque France 31 2.1k 1.5× 201 0.2× 645 1.3× 369 1.0× 55 0.2× 87 3.3k
Dana Cavill Australia 11 929 0.6× 276 0.3× 183 0.4× 153 0.4× 42 0.1× 14 1.7k

Countries citing papers authored by Mary Rieck

Since Specialization
Citations

This map shows the geographic impact of Mary Rieck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Rieck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Rieck more than expected).

Fields of papers citing papers by Mary Rieck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Rieck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Rieck. The network helps show where Mary Rieck may publish in the future.

Co-authorship network of co-authors of Mary Rieck

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Rieck. A scholar is included among the top collaborators of Mary Rieck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Rieck. Mary Rieck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erkers, Tom, Bryan J. Xie, Mary Rieck, et al.. (2020). High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity. Blood. 135(11). 814–825. 12 indexed citations
2.
Williams, Kiah M., Hanjay Wang, Michael J. Paulsen, et al.. (2020). Safety of photosynthetic Synechococcus elongatus for in vivo cyanobacteria–mammalian symbiotic therapeutics. Microbial Biotechnology. 13(6). 1780–1792. 27 indexed citations
3.
Pieper, Jennifer, Anatoly Dubnovitsky, Christina Gerstner, et al.. (2018). Memory T cells specific to citrullinated α-enolase are enriched in the rheumatic joint. Journal of Autoimmunity. 92. 47–56. 43 indexed citations
4.
Gerstner, Christina, Anatoly Dubnovitsky, Charlotta Sandin, et al.. (2016). Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis. Frontiers in Immunology. 7. 1236–1236. 51 indexed citations
5.
Kuipers, Hedwich F., Mary Rieck, Irina Gurevich, et al.. (2016). Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization. Proceedings of the National Academy of Sciences. 113(5). 1339–1344. 54 indexed citations
6.
Bluestone, Jeffrey A., Jane H. Buckner, Mark Fitch, et al.. (2015). Type 1 diabetes immunotherapy using polyclonal regulatory T cells. Science Translational Medicine. 7(315). 810 indexed citations breakdown →
7.
James, Eddie A., Mary Rieck, Jennifer Pieper, et al.. (2014). Citrulline‐Specific Th1 Cells Are Increased in Rheumatoid Arthritis and Their Frequency Is Influenced by Disease Duration and Therapy. Arthritis & Rheumatology. 66(7). 1712–1722. 158 indexed citations
8.
Bollyky, Jenna, S. Alice Long, Mark Fitch, et al.. (2013). Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes. Clinical & Experimental Immunology. 172(3). 363–374. 10 indexed citations
9.
Pieper, Jennifer, Sven‐Erik Johansson, Omri Snir, et al.. (2013). Peripheral and Site‐Specific CD4+CD28null T Cells from Rheumatoid Arthritis Patients Show Distinct Characteristics. Scandinavian Journal of Immunology. 79(2). 149–155. 36 indexed citations
10.
Long, S. Alice, Mary Rieck, Srinath Sanda, et al.. (2013). Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. 15. 2 indexed citations
11.
Long, S. Alice, Mary Rieck, Srinath Sanda, et al.. (2012). Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function. Diabetes. 61(9). 2340–2348. 255 indexed citations
12.
Stone, Brad, et al.. (2012). Identification of novel HLA class II target epitopes for generation of donor-specific T regulatory cells. Clinical Immunology. 145(2). 153–160. 2 indexed citations
13.
Snir, Omri, Mary Rieck, John A. Gebe, et al.. (2011). Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients. Arthritis & Rheumatism. 63(10). 2873–2883. 124 indexed citations
14.
Habib, Tania, Mary Rieck, Archana Brahmandam, et al.. (2011). Altered B Cell Homeostasis Is Associated with Type I Diabetes and Carriers of the PTPN22 Allelic Variant. The Journal of Immunology. 188(1). 487–496. 105 indexed citations
15.
Long, S. Alice, Mindi Walker, Mary Rieck, et al.. (2009). Functional islet‐specific Treg can be generated from CD4+CD25 T cells of healthy and type 1 diabetic subjects. European Journal of Immunology. 39(2). 612–620. 39 indexed citations
16.
Schneider, Anya, Mary Rieck, Srinath Sanda, et al.. (2008). The Effector T Cells of Diabetic Subjects Are Resistant to Regulation via CD4+FOXP3+ Regulatory T Cells. The Journal of Immunology. 181(10). 7350–7355. 255 indexed citations
17.
Rieck, Mary, Adrian F. Arechiga, Suna Önengüt-Gümüşcü, et al.. (2007). Genetic Variation in PTPN22 Corresponds to Altered Function of T and B Lymphocytes. The Journal of Immunology. 179(7). 4704–4710. 266 indexed citations
18.
Thielen, Beth K, et al.. (2007). T Cells Contain an RNase-Insensitive Inhibitor of APOBEC3G Deaminase Activity. PLoS Pathogens. 3(9). e135–e135. 39 indexed citations
19.
Holzer, Ursula, Mary Rieck, & James S. Buckner. (2006). Lineage and signal strength determine the inhibitory effect of transforming growth factor β1 (TGF-β1) on human antigen-specific Th1 and Th2 memory cells. Journal of Autoimmunity. 26(4). 241–251. 14 indexed citations
20.
Rieck, Mary & Julie Moreland. (2005). The Orpington Prognostic Scale for patients with stroke: Reliability and pilot predictive data for discharge destination and therapeutic services. Disability and Rehabilitation. 27(23). 1425–1433. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026